• OPEN AN ACCOUNT
Indian Indices
Sensex
77,656.09 286.98
( 0.37%)
Global Indices
Nasdaq
53,439.07 141.06
(0.26%)
Dow Jones
7,673.94 -21.43
(-0.28%)
Hang Seng
65,802.43 274.34
(0.42%)
Nikkei 225
10,857.89 41.33
(0.38%)
Forex
USD-INR
95.63 -0.04
(-0.04%)
EUR-INR
111.66 -0.10
(-0.09%)
GBP-INR
130.46 0.10
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.5524281
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.61
16.91
EPS(TTM)
Face Value()
Div & Yield %
0.46
10
0
 

Astral consolidated net profit rises 18.80% in the March 2026 quarter
May 18,2026
Net profit of Astral rose 18.80% to Rs 213.00 crore in the quarter ended March 2026 as against Rs 179.30 crore during the previous quarter ended March 2025. Sales rose 24.21% to Rs 2088.50 crore in the quarter ended March 2026 as against Rs 1681.40 crore during the previous quarter ended March 2025.

For the full year,net profit rose 2.08% to Rs 534.70 crore in the year ended March 2026 as against Rs 523.80 crore during the previous year ended March 2025. Sales rose 12.62% to Rs 6568.60 crore in the year ended March 2026 as against Rs 5832.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2088.501681.40 24 6568.605832.40 13
OPM %18.3317.96 -16.1716.22 -
PBDT376.70301.20 25 1044.80945.90 10
PBT302.70236.40 28 753.20702.50 7
NP213.00179.30 19 534.70523.80 2